Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ALKEM LABORATORIES DIVIS LABORATORIES/
ALKEM LABORATORIES
 
P/E (TTM) x 30.0 33.2 90.2% View Chart
P/BV x 7.7 4.3 177.5% View Chart
Dividend Yield % 0.9 1.1 81.3%  

Financials

 DIVIS LABORATORIES   ALKEM LABORATORIES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
ALKEM LABORATORIES
Mar-22
DIVIS LABORATORIES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs5,4254,068 133.4%   
Low Rs3,5622,671 133.4%   
Sales per share (Unadj.) Rs337.5889.4 37.9%  
Earnings per share (Unadj.) Rs111.5140.5 79.4%  
Cash flow per share (Unadj.) Rs123.3166.0 74.3%  
Dividends per share (Unadj.) Rs30.0034.00 88.2%  
Avg Dividend yield %0.71.0 66.2%  
Book value per share (Unadj.) Rs441.8722.4 61.2%  
Shares outstanding (eoy) m265.47119.57 222.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.33.8 351.4%   
Avg P/E ratio x40.324.0 168.1%  
P/CF ratio (eoy) x36.520.3 179.6%  
Price / Book Value ratio x10.24.7 218.1%  
Dividend payout %26.924.2 111.2%   
Avg Mkt Cap Rs m1,192,890402,868 296.1%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46219,627 48.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598106,342 84.3%  
Other income Rs m1,1591,627 71.3%   
Total revenues Rs m90,757107,968 84.1%   
Gross profit Rs m38,81120,380 190.4%  
Depreciation Rs m3,1153,040 102.5%   
Interest Rs m20524 3.8%   
Profit before tax Rs m36,83518,443 199.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2311,640 441.0%   
Profit after tax Rs m29,60516,803 176.2%  
Gross profit margin %43.319.2 226.0%  
Effective tax rate %19.68.9 220.8%   
Net profit margin %33.015.8 209.1%  
BALANCE SHEET DATA
Current assets Rs m96,10484,354 113.9%   
Current liabilities Rs m24,54448,053 51.1%   
Net working cap to sales %79.934.1 234.0%  
Current ratio x3.91.8 223.1%  
Inventory Days Days942 20.8%  
Debtors Days Days98765 1,526.5%  
Net fixed assets Rs m50,08743,245 115.8%   
Share capital Rs m531239 222.0%   
"Free" reserves Rs m116,75186,134 135.5%   
Net worth Rs m117,28286,373 135.8%   
Long term debt Rs m094 0.0%   
Total assets Rs m146,191127,599 114.6%  
Interest coverage x1,842.836.2 5,088.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 73.5%   
Return on assets %20.313.6 149.2%  
Return on equity %25.219.5 129.8%  
Return on capital %31.421.9 143.3%  
Exports to sales %018.7 0.0%   
Imports to sales %19.70-   
Exports (fob) Rs mNA19,924 0.0%   
Imports (cif) Rs m17,676NA-   
Fx inflow Rs m78,44519,924 393.7%   
Fx outflow Rs m17,9533,911 459.1%   
Net fx Rs m60,49216,013 377.8%   
CASH FLOW
From Operations Rs m19,11811,110 172.1%  
From Investments Rs m-21,949-14,351 152.9%  
From Financial Activity Rs m-5,3243,796 -140.3%  
Net Cashflow Rs m-8,156580 -1,407.1%  

Share Holding

Indian Promoters % 51.9 57.2 90.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 20.2 179.2%  
FIIs % 15.4 4.5 345.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 42.8 112.2%  
Shareholders   379,257 79,721 475.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Divis Laboratories vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs ALKEM LABORATORIES Share Price Performance

Period Divis Laboratories ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -1.17% -0.45% -0.10%
1-Month -10.59% -6.02% -1.99%
1-Year -29.25% -10.25% -5.62%
3-Year CAGR 23.71% 15.27% 20.96%
5-Year CAGR 26.77% 9.10% 11.47%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of ALKEM LABORATORIES the stake stands at 57.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

ALKEM LABORATORIES paid Rs 34.0, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.